TAK-041
Also Known As:
2-(4-oxo-1,2,3-benzotriazin-3-yl)-N-((1S)-1-(4-(trifluoromethoxy)phenyl)ethyl)acetamide; TAK041
Networked: 2
relevant articles (1 outcomes,
1 trials/studies)
Relationship Network
Bio-Agent Context: Research Results
Experts
1. | Arkilo, Dimitrios:
1 article
(01/2022)
|
2. | Baader-Pagler, Tamara:
1 article
(01/2022)
|
3. | Behrje, Rhett:
1 article
(01/2022)
|
4. | Bretschneider, Tom:
1 article
(01/2022)
|
5. | Deiana, Serena:
1 article
(01/2022)
|
6. | Ferger, Boris:
1 article
(01/2022)
|
7. | Han, David:
1 article
(01/2022)
|
8. | Hauber, Wolfgang:
1 article
(01/2022)
|
9. | Khudyakov, Polyna:
1 article
(01/2022)
|
10. | Klinder, Klaus:
1 article
(01/2022)
|
Related Diseases
Related Drugs and Biologics
Related Therapies and Procedures